Breaking News
Get 40% Off 0
🎁 Free Gift Friday: Copy Legendary Investors' Portfolios in One Click Copy for Free

Search Results for "MITO":

Results: 313

Quotes

8622 Mito Securities Co Ltd Stock - Tokyo equities MINI Miton UK MicroCap Trust PLC Stock - London equities 0P00015BC2 Premier Miton Multi-asset Monthly Income C Accumulation Fund - London fund 0P0000XT98 Premier Miton Multi-asset Monthly Income B Income Fund - London fund 0P0000XOAD Premier Miton Multi-asset Growth & Income C Income Fund - London fund 0P00015BC1 Premier Miton Multi-asset Growth & Income C Accumulation Fund - London fund 0P0000XOAC Premier Miton Multi-asset Growth & Income B Income Fund - London fund 0P00007ZYL Premier Miton Multi-asset Growth & Income A Income Fund - London fund
Show all (52)

News

Lowell Farms to Announce First Quarter 2024 Financial and Operational Results
By Investing.com

SALINAS, Calif., May 09, 2024 (GLOBE NEWSWIRE) -- Lowell Farms Inc.  (CSE:LOWL; OTCQX:LOWLF), a California-born cannabis company with advanced production capabilities including extraction,...

Amylyx Pharmaceuticals Reports First Quarter 2024 Financial Results
By Investing.com

Company plans to engage with FDA based on interim data from the Phase 2 HELIOS clinical trial demonstrating improvements in pancreatic function, glycemic control, and vision in participants with...

eFFECTOR Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
By Investing.com

Dose escalation of zotatifin in the ZFA triplet ongoing at 0.14 mg/kg, with RP2D expected in H2 2024 Raised $15.0 million in gross proceeds from registered direct financing, extending cash runway into...

Show all (210)

Analysis

Company News For Oct 11, 2019
By Zacks Investment Research

Shares of Ra Pharmaceuticals, Inc. (NASDAQ:MITO) jumped 11.8% after the company announced that it will collaborate with Alexion (NASDAQ:ALXN) to develop elamipretide which can treat mitochondrial...

Stealth BioTherapeutics Sees Hammer Chart Pattern: Time To Buy?
By Zacks Investment Research

Stealth BioTherapeutics Corp (NASDAQ:S&P 500) gained +15.8%, five of our screens returned +38.0%, +61.3%, +61.6%, +68.1%, and +98.3%.This outperformance has not just been a recent phenomenon....

Alexion (ALXN) Up 10 % YTD On Soliris & Ultomiris Strength
By Zacks Investment Research

Shares of Alexion Pharmaceuticals, Inc. (NASDAQ:MITO) for a late-stage therapy for mitochondrial diseases. Both companies announced an agreement to co-develop and commercialize elamipretide, a...

Show all (51)
Results: 52

Refine Results

Instrument Type

Region

 

Country

Exchange

Sector

 

Industry

 
Results: 210

Refine Results

Date

Date
 

Category

Provider

 

News

{{title}}
By {{provider}}

{{content}}

Please try another search

Results: 51

Refine Results

Date

Date
 

Category

Author

Analysis

{{title}}
By {{provider}}

{{content}}

Results: 0

Refine Results

Country

Importance

Economic Events

Results: 0

Tools & Sections

Results: 0

Authors

Continue with Google
or
Sign up with Email